Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data Purple Innovation, Inc. files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Revenue
197
286
428
648
725
573
511
488
469
Cost of revenue
112
173
239
343
431
365
339
307
280
Gross profit
85
113
189
305
294
208
172
181
189
Research and development
1.39
2.1
3.86
5.96
6.94
8.76
11.9
13
9.6
Selling and marketing
79.1
104
142
188
239
165
182
171
147
General and administrative
2.66
13.2
23.6
26.9
39.9
72.1
76.7
84.4
69.1
63.6
Operating expenses
93.8
129
173
234
318
251
286
273
232
Operating income
-2.66
-8.75
-16.9
16.2
71.2
-24.6
-42.8
-114
-92.2
-43
Interest expense
0.08
3.73
5.18
4.65
1.87
3.54
1.97
17.5
28.8
Interest income
0.33
1.04
1.83
29.8
Other non-operating income
0.33
3.43
-2.72
-46.7
-345
26
163
-7.5
-5.85
-8.28
Pre-tax income
-2.33
1.21
-19.6
-30.5
-274
1.43
120
-121
-98
-51.3
Income tax
0.41
0.4
-43.7
-1.52
213
0.01
0.06
0.21
Net income to minority interests
-15.3
-8.35
7.09
-0.17
-0.25
-0.46
-0.2
-0.1
Net income
-2.33
-8.82
-4.32
-22.6
-237
3.11
-92.5
-121
-97.9
-51.4
EBITDA
-8.01
-14.7
20.5
79.1
-15.1
-25.3
-88.6
-56.8
-19
EPS, basic
-2.77
-5.93
-2.88
-2.26
-6.04
0.05
-1.13
1.17
0.91
0.48
EPS, diluted
-2.77
-5.93
-2.88
-2.26
-6.04
-0.31
-1.13
1.17
0.91
0.48
Shares, basic (weighted)
0.85
0.88
1.49
10
39.2
65.9
81.8
104
107
108
Shares, diluted (weighted)
0.85
3.13
1.49
10
39.2
67.3
81.8
104
107
108
Balance sheet
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Cash and equivalents
4.01
3.59
12.2
33.5
123
91.6
41.8
26.9
29
24.3
Receivables
4.18
10.2
28.7
29.1
25.4
34.6
37.8
33.1
41.3
Inventory
13.3
22.9
47.6
65.7
98.7
73.2
66.9
56.9
59.7
Other current assets
0.04
0.49
1.49
3.44
4.56
5.7
4.12
1.74
1.41
5.89
Total current assets
0.28
22.9
47.7
114
229
230
161
142
126
137
Property, plant and equipment
13.5
22.5
32
61.5
113
137
129
93.9
78
Lease right-of-use assets
41.4
68
103
95.8
75.5
67.3
Goodwill
4.9
6.9
Intangible assets
1.27
1.49
1.1
9.95
13.2
26.2
22.2
8.89
6.35
Other non-current assets
0.02
0.01
0.53
1.58
1.32
1.55
2.19
3.2
7.96
Total assets
156
37.7
71.7
148
555
642
433
391
308
296
Accounts payable
0.2
21.1
24.8
50.2
69.6
79.8
46.4
49.8
40.6
40.3
Accrued liabilities
1.61
0.18
0.36
0.25
14.2
8.93
6.69
0.51
2.99
2.26
Deferred revenue
5.72
6.41
5.28
Short-term debt
0.03
0.03
2
96.4
23.7
29
55.4
Total current liabilities
1.88
41.2
48.6
86.9
132
142
98.1
111
101
102
Long-term debt
8
21.4
35.4
43.4
96.4
23.7
26.9
Lease liabilities
48.9
81.2
116
109
87.1
75.6
Other non-current liabilities
8.57
6.5
12.1
18.7
2.24
2.01
1.76
Total liabilities
6.53
51.6
73.7
176
487
496
258
275
288
326
Total debt
8
26.6
35.4
41.4
94.1
23.7
26.9
70.7
127
Paid-in capital
7.63
6.83
3.66
2.82
333
408
529
591
594
596
Retained earnings
-2.63
-1.83
-4.32
-29
-266
-262
-355
-476
-574
-625
Shareholders' equity
5
5
-0.66
-26.2
67.2
146
174
115
20.2
-29.7
Minority interests
-1.35
-2.38
0.34
0.77
0.91
0.19
0.01
0.02
Total equity
-0.81
-13.9
-7.27
-28.5
67.5
146
175
116
20.2
-29.7
Total liabilities and equity
156
37.7
71.7
148
555
642
433
391
308
296
Shares outstanding
0.88
0.86
Cash flow statement
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2023
FY2024
FY2025
Net income
-2.33
-8.82
-19.6
-30.9
-230
2.95
-92.7
-121
-98.1
-51.5
Depreciation and amortization
0.74
2.2
4.31
7.9
9.47
17.5
25.1
35.4
24.1
Stock-based compensation
0.49
10.1
2.19
3.37
3.37
4.88
2.82
1.73
Deferred income tax
-24.7
-18.1
-3.61
214
-0.04
Change in receivables
-1.86
-6.06
-18.5
-0.42
3.68
-4.11
-3.65
4.75
-8.22
Change in inventory
-8.01
-9.6
-24.7
-33
29
5.9
5.99
-2.86
Change in payables
1.68
13.8
3.78
25.1
16
6.8
-33.6
4.38
-6.38
0.06
Cash from operations
-0.81
5
-21.7
22.9
81.3
-30.9
-28.8
-54.7
-17.9
-33.8
Capital expenditures
-7.58
-11.3
-10.5
-27.9
-53.9
-35.4
-14.4
-7.24
-8.08
Acquisitions
3.66
-0.83
Cash from investing
-8.73
-11.7
-10.8
-39.1
-57.1
-34.5
-16.1
-7.53
-8.28
Debt issued
45
Debt repaid
-0.56
-2.25
-17.5
-24.7
-25
Stock issued
26.3
2.01
1.42
0.17
Share buybacks
-34.2
-0.1
Dividends paid
-0.1
Cash from financing
3.31
41.9
9.15
47.4
56.6
13.4
55.8
27.5
37.4
Net change in cash
-0.81
-0.42
8.64
21.2
89.5
-31.3
-49.9
-14.9
2.15
-4.67
Free cash flow
-2.58
-33
12.4
53.4
-84.8
-64.1
-69.1
-25.1
-41.9
Interest paid
0.05
0.05
1.38
1.87
8.17
1
2.69
0.19
0.16
0.15
Income taxes paid
0.07
0.26
0.12
2.06
-4.65
0.3
0.39
0.32
0.18
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $1.81 on November 11, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
40.7%
Gross profit / revenue.
Operating margin
-7.8%
Operating income / revenue.
EBITDA margin
-3.1%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
-10.7%
Pre-tax income / revenue.
Net margin
-10.7%
Net income / revenue.
FCF margin
-2.1%
Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin
-0.7%
Cash from operations / revenue.
Return on assets (ROA)
-18.4%
Net income / average total assets.
R&D / revenue
2.2%
Research and development expense / revenue.
Stock-based pay / revenue
0.1%
Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue
1.4%
Capital expenditures / revenue.
D&A / revenue
4.7%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
-3.9%
Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y
-6.5%
Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y
-6.3%
Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y
4.1%
Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y
-3.2%
Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y
-9.2%
Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y
-47.3%
EPS vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
-247.0%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
-3.8%
Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y
-11.9%
Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y
-11.8%
Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y
0.9%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y
9.8%
Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y
22.5%
Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
0.52x
Current assets / current liabilities.
Quick ratio
0.23x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.11x
(Cash + short-term investments) / current liabilities.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
-$11.17
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$104.00
Revenue / diluted weighted shares.
FCF per share
-$2.19
Free cash flow / diluted weighted shares.
Operating cash flow per share
-$0.72
Cash from operations / diluted weighted shares.
Book value per share
-$14.63
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/S
0.02x
Market cap / revenue.
FCF yield
-121.2%
Free cash flow / market cap.
Earnings yield
-618.1%
Net income / market cap (the inverse of P/E).
What was Purple Innovation, Inc.'s revenue in fiscal 2025?
Purple Innovation, Inc. reported revenue of $468.7M for fiscal 2025, 3.9% lower than the year before.
Was Purple Innovation, Inc. profitable in fiscal 2025?
No. It reported a net loss of $51.4M.
How much free cash flow did Purple Innovation, Inc. generate in fiscal 2025?
Cash from operations of $33.8M minus capital expenditures of $8.1M left free cash flow of -$41.9M.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.